It was a bittersweet return home for Kevin Shattenkirk, as the kid from New Rochelle who grew up rooting for the Rangers made his debut for the Blueshirts during their season-opening 4-2 loss to the Avalanche on Thursday night at the Garden. “I think the result still stings right now,” Shattenkirk said after he finished...
NYS Entity Status
NYS Filing Date
FEBRUARY 15, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - INSTITUTE 4 INCREASED PERFORMANCE, INC.
Around the Web
- This wasn’t the homecoming Kevin Shattenkirk envisioned
By Brett Cyrgalis - Friday Oct 6, 2017
- The Look: New York City Parks in the Summer: Romance, Games and a Performance for a Dying Tree
By DANIEL ARNOLD, JOANNA NIKAS and EVE LYONS - Saturday Sep 2, 2017
Daniel Arnold spent the last two months photographing parks in all five boroughs. The experience showed him “a very different pulse of the city.”
- World Music Institute Expands for Next Concert Season
By ANDREW R. CHOW - Monday Jul 24, 2017
John Zorn, Tanya Tagaq and Black Coffee will be among the musicians performing for this nonprofit organization’s season.
- NY's Hometown Paper Once Again Owned By Chicago Publisher
Tuesday Sep 5, 2017
New York's hometown paper is once again owned by a Chicago-based newspaper holding company, following the 'New York Daily News' sale on Monday to Tronc Inc. In a way, it's like deja vu. Tronc wasformerly Tribune Publishing, the publisher of the 'Chicago Tribune,' which originally created the 'New York Daily News' nearly a century ago.
- Internet Giants Face New Political Resistance in Washington
By CECILIA KANG - Wednesday Sep 20, 2017
Facebook, Google and Amazon are coming under increasing pressure by regulators concerned about their growing power.
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]